Posted inMarket FDA Approves Sagimet Biosciences to Launch Phase 3 Trial for Denifanstat in Acne TreatmentSagimet Biosciences receives FDA clearance to begin Phase 3 clinical trials for denifanstat as a novel acne treatment option. Posted by Prasenjit Bhowmik September 4, 2026
